Outcome of narcotic addict treatment in California. In: Tims, F.M., Ludford, J. P. Drug Abuse Treatment Evaluation: Strategies, Progress and Prospects. Rockville, MD: National Institute of Drug Abuse; 1984: 106-128. US Department of Health and Human Services publication ADM 88-1329. NIDA Research Monograph 51.
Methadone treatment and legal supervision: individual and joint effects on the behavior of narcotics addicts. Journal of Applied Behavioral Science. 1991; 27(4):515-531.
Cost-effectiveness analysis of drug abuse treatment: Current status and recommendations for future research. In: Background Papers on Drug Abuse Financing and Services Research. Rockville, MD: National Institute of Drug Abuse Services Research Series; 1991: 58-81. US Department of Health and Human Services publication ADM 91-1777.
Patient characteristics associated with retention in a methadone maintenance program. British Journal of the Addictions of Alcohol and Other Drugs.1971; 66(3):195-204.
Just another habit? The heroin user's perspective on treatment. In: Hanson, B., Beschner, G., Walters, J.M., Bovelle, E., eds. Life With Heroin: Voices from the Inner City. Lexington, MA: Lexington Books; 1985: 155-173.
Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. Journal of Substance Abuse Treatment. 1991; 8(4): 203-212.
Psychotherapy and chemical dependence. In: Ciraulo, D.A., Shader, R.I., eds. Clinical Manual of Chemical Dependence. Washington, DC: American Psychiatric Press; 1991.
Do methadone patients substitute other drugs for heroin? Predicting substance abuse at 1-year follow-up. American Journal of Drug and Alcohol Abuse.1993; 19(4):465-474.
Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and -seronegative intravenous drug users. Journal of the American Medical Association. 1992; 267(3):369-373.
Methadone dose and duration for maintenance treatment. In: Cooper, J.R., Allman, F., Brown, B.S., Czechowicz, D., eds. Research on the Treatment of Narcotic Addiction: State of the Art. Washington, DC: US Government Printing Office; 1983.
Methadone maintenance treatment and reduced risk of AIDS and AIDS-specific mortality in intravenous drug users. Abstract No. 8546. Proceedings of the Fourth International Conference on AIDS. Stockholm; 1988.
HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam. American Journal of Public Health.1992; 82(4):547-551.
Economic Costs to Society of Alcohol and Drug Abuse and Mental Illness: 1980. Contract RTI/2734/00-01FR. Research Triangle Park, NC: Research Triangle Institute; 1984.
Relapse to use of heroin, cocaine, and other drugs in the first year after treatment. In: Tims, F.M., Leukefeld, C.G., eds. Relapse and Recovery in Drug Abuse. Rockville, MD: National Institute on Drug Abuse; 1986; 157-166. US Department of Health and Human Services publication ADM 88-1473. NIDA Research Monograph 72.
It takes your heart: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. International Journal of the Addictions. 1985; 20(11-12):1751-1771.
Treating Drug Problems, Volume 1: A Study of the Evolution, Effectiveness and Financing of Public and Private Drug Treatment Systems. Washington, DC: National Academy Press; 1990b.
Highlights from Drugs and American High School Students: 1975-1977. Rockville, MD: National Institute on Drug Abuse; 1984. US Department of Health and Human Services publication ADM 84-1317.
Client issues in drug abuse treatment: addressing multiple drug abuse. In: Pickens, R.W., Leukefeld, C.G., Schuster, C.R., eds. Improving Drug Abuse Treatment. Rockville, MD: National Institute on Drug Abuse; 1991: 136-151. US Department of Health and Human Services publication ADM 91-1754. NIDA Research Monograph 106.
Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Archives of General Psychiatry. 1992; 49(11):894-898.
Using methadone effectively: achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. In: Pickens, R.W., Leukefeld, C.G., Schuster, C.R., eds. Improving Drug Abuse Treatment. Rockville, MD: National Institute on Drug Abuse; 1991: 245-266. US Department of Health and Human Services publication ADM 91-1754. NIDA Research Monograph 106.
Methadyl acetate and methadone as maintenance treatments for heroin addicts: a Veterans Administration cooperative study. Archives of General Psychiatry.1976; 33(6):709-720.
Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels. Psychopharmacology.1991; 103(4):538-540.
Special manual for dynamic therapy of drug dependence: adaptation of the general manual for supportive-expressive psychotherapy. In: Barber J., Crits-Christoph, P., eds. Psychodynamic Psychotherapies for Axis I Disorders. New York, NY: Basic Books; 1994.
Treatment history. In: Simpson, D.D., Sells, S.B., eds. Opioid Addiction and Treatment: A 12-Year Follow-Up. Malabar, FL: Robert E. Krieger Publishing Company; 1990: 137-156.
Patient treatment matching: a conceptual and methodological review with suggestions for future research. In: Pickens, R.W., Leukefeld, C.G., Schuster, C.R., eds. Improving Drug Abuse Treatment. Rockville, MD: National Institute on Drug Abuse; 1991: 114-135. US Department of Health and Human Services. publication ADM 91-1754. NIDA Research Monograph 106.
A new measure of substance abuse treatment: initial studies of the treatment services review. Journal of Nervous and Mental Disease. 1992; 180(2):101-110.
An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease.1980; 168(1):26-33.
Increased effectiveness of substance abuse treatment: a prospective study of patient-treatment matching. Journal of Nervous and Mental Disorders. 1983b; 171(10): 597-605.
Is the counselor an "active ingredient" in substance abuse rehabilitation? An examination of treatment success among four counselors. Journal of Nervous and Mental Disease. 1988; 176(7):423-430.
Background Papers on Drug Abuse Financing and Services Research. Drug Abuse Services Research Series. DHHS publication ADM 91-1777. Rockville, MD: National Institute on Drug Abuse; 1991.
National Drug and Alcoholism Treatment Unit Survey (NDATUS): 1991 Main Findings Report. Rockville, MD; 1993. Department of Health and Human Services SMA 93-2007.
Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine. 1990; 150(1):97-99.
State Methadone Maintenance Treatment Guidelines. Rockville, MD: Center for Substance Abuse Treatment, US Department of Health and Human Services; 1993.
Drug Abuse Treatment Cost Analysis Program (DATCAP): Cost Interview Guide for Provider Sites. A Training and Employment Program (TEP). Research Triangle Park, NC: Research Triangle Institute; 1993.
Diagnostic Source Book on Drug Abuse Research and Treatment. Rockville, MD: National Institute on Drug Abuse; 1993. US Department of Health and Human Services publication ADM 93-3508.
Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Archives of General Psychiatry. 1982a; 39(2): 151-156.
Substance abuse among Hispanic-Americans: current issues and future perspectives. In: Lowinson, J., Ruiz, P., Millman, R., eds. Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams & Wilkins; 1992.
Cultural perspectives: Native Americans, Asians, and new immigrants. In: Lowinson, J., Ruiz, P., Millman, R., eds. Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams & Wilkins; 1992.
The DATAR Project: cognitive and behavioral enhancements to community-based treatment. In: Tims, F.M., Fletcher, B.W., Inciardi, J.A., Delaney, P., Harden, A. M., eds. The Effectiveness of Innovative Strategies in the Treatment of Drug Abuse. Westport, CT: Greenwood Press. 1995.
Relapse and recovery among opioid addicts 12 years after treatment. In: Tims, F.M., Leukefeld, C.G., eds. Relapse and Recovery in Drug Abuse. Rockville, MD: National Institute on Drug Abuse; 1986: 86-103. US Department of Health and Human Services publication 88-1473. NIDA Research Monograph 72.
Treatment re-entry and outcomes of opioid addicts during a four-year follow-up after drug abuse treatment in the United States. Bulletin on Narcotics. 1980; 32(4):1-10.
Contingent take-home incentive: effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology. 1992; 60(6):927-934.
Drug Abuse Treatment Evaluation: Strategies, Progress and Prospects. Rockville, MD: National Institute on Drug Abuse; 1984. US Department of Health and Human Services publication ADM 88-1329. NIDA Research Monograph 51.
Towards a rehabilitation of methadone maintenance: integration of relapse prevention and aftercare. International Journal of the Addictions. 1991; 25(9A-10A):1201-1224.
The health of the homeless: evidence from the National Health Care for the Homeless Program. In: Brickner, P. et al., eds. Under the Safety Net: The Health and Social Welfare of the Homeless in the United States. New York, NY: W.W. Norton. 1990:15-31.
Drugs Used for Treatment of Narcotic Addicts, 21 C.F.R. Part 291 Section 291.
501 (Methadone and the Maintenance Treatment of Narcotic Addicts), Section
291.505 (Conditions for the Use of Narcotic Drugs; Appropriate Methods of Professional
Practice for Medical Treatment of the Narcotic Addictions of Various Classes of
Narcotic Addicts Under Section 4 of the Comprehensive Drug Abuse Protection and
Control Act of 1970) (1993).